Is there a role for diastolic function assessment in era of delayed enhancement cardiac magnetic resonance imaging? A multimodality imaging study in patients with advanced ischemic cardiomyopathy

Background Cardiac magnetic resonance (CMR) identifies important prognostic variables in ischemic cardiomyopathy (ICM) patients such as left ventricular (LV) volumes, LV ejection fraction (LVEF), peri-infarct zone, and myocardial scar burden (MSB). It is unknown whether Doppler-based diastolic dysfunction (DDF) retains its prognostic value in ICM patients, in the context of current imaging, medical, and device therapies. Methods Diastolic function was evaluated in ICM patients (LVEF 40% and ≥70% stenosis in ≥1 coronary artery) who underwent transthoracic echocardiogram and delayed hyperenhancement CMR studies within 7 days. The association of DDF with the combined end point was assessed after risk-adjustment using Cox proportional hazards models. Results A total of 360 patients with severe LV dysfunction (LVEF = 249%) and extensive MSB (3117%) were evaluated; DDF was present in all patients (stage 1%-44%, stage 2%-25%, stage 3%-31%). There were 130 events (124 deaths and 6 heart transplants) over a median follow-up of 5.8 years (IQR, 3.7-7.4 years). On multivariable analysis, DDF stage 1 (HR, 1.37; P =.007) was associated with the combined end-point, independent of clinical risk score (HR, 2.40; P 0001), implantable cardioverter defibrillator implantation (HR, 0.60; P =.009), incomplete revascularization (HR, 1.32; P =.003), mitral regurgitation (HR, 3.37; P =.01), peri-infarct zone area (HR, 1.04; P = 0.02), and MSB (HR, 1.02; P =.01). DDF had incremental prognostic value for the combined end-point (model χ;bsupesupincreased from 89 to 95, P =.02). Conclusion DDF is a powerful predictor of mortality in ICM patients with significant LV dysfunction, independent of clinical and CMR data. DDF assessment provides incremental value, improving risk stratification.